Evidence map›Paper›PMID 34032268›Full record

ArticleDevelopment (Cambridge, England)2021

Postnatal prolongation of mammalian nephrogenesis by excess fetal GDNF.

Hao Li, Kristen Kurtzeborn, Jussi Kupari, Yujuan Gui, Edward Siefker, Benson Lu, Kärt Mätlik, Soophie Olfat, Ana R Montaño-Rodríguez, Sung-Ho Huh and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Development (Cambridge, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Epigenetic regulation of kidney development.Nature reviews. Nephrology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Heliyon · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Protective role of endorepellin in renal developmental programming.Frontiers in cell and developmental biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Hao LiStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
Kristen KurtzebornStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
Jussi KupariStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
Yujuan GuiStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
Edward SiefkerDepartment of Developmental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68105, USA.
Benson LuDepartment of Genetics and Development, Columbia University Medical Center, New York, NY 10032, USA.ORCID 0000-0001-7080-4897
Kärt MätlikHelsinki Institute of Life Science, University of Helsinki, 00014 Helsinki, Finland.
Soophie OlfatHelsinki Institute of Life Science, University of Helsinki, 00014 Helsinki, Finland.
Ana R Montaño-RodríguezHelsinki Institute of Life Science, University of Helsinki, 00014 Helsinki, Finland.
Sung-Ho HuhDepartment of Developmental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68105, USA.
Franklin CostantiniDepartment of Genetics and Development, Columbia University Medical Center, New York, NY 10032, USA.
Jaan-Olle AndressooHelsinki Institute of Life Science, University of Helsinki, 00014 Helsinki, Finland.
Satu KuureStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.ORCID 0000-0002-9076-0622
University of Helsinki · FIColumbia University Irving Medical Center · USUniversity of Nebraska Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nephron endowment, defined during the fetal period, dictates renal and related cardiovascular health throughout life. We show here that, despite its negative effects on kidney growth, genetic increase of GDNF prolongs the nephrogenic program beyond its normal cessation. Multi-stage mechanistic analysis revealed that excess GDNF maintains nephron progenitors and nephrogenesis through increased expression of its secreted targets and augmented WNT signaling, leading to a two-part effect on nephron progenitor maintenance. Abnormally high GDNF in embryonic kidneys upregulates its known targets but also Wnt9b and Axin2, with concomitant deceleration of nephron progenitor proliferation. Decline of GDNF levels in postnatal kidneys normalizes the ureteric bud and creates a permissive environment for continuation of the nephrogenic program, as demonstrated by morphologically and molecularly normal postnatal nephron progenitor self-renewal and differentiation. These results establish that excess GDNF has a bi-phasic effect on nephron progenitors in mice, which can faithfully respond to GDNF dosage manipulation during the fetal and postnatal period. Our results suggest that sensing the signaling activity level is an important mechanism through which GDNF and other molecules contribute to nephron progenitor lifespan specification.

Indexed as

AnimalsAxin ProteinCell DifferentiationGlial Cell Line-Derived Neurotrophic FactorMiceMice, Inbred C57BLMice, KnockoutNephronsOrganogenesisStem CellsWnt ProteinsWnt Signaling PathwayAxin2 protein, mouseAxin ProteinGdnf protein, mouseGlial Cell Line-Derived Neurotrophic FactorWnt9b protein, mouseWnt ProteinsDifferentiationKidneyMouseNephrogenesisNephron progenitors

Identifiers

PMID34032268
PMCPMC8180252
OpenAlexW3164130688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.